Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Professional Licensing topic

No spam. Unsubscribe anytime.

CNS advisory panel directs staff to draft rule requiring national certification for licensure

Clinical Nurse Specialist Advisory Committee (CNSAC), California Board of Registered Nursing · April 2, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

The Clinical Nurse Specialist Advisory Committee voted to ask staff to draft regulatory language that would require national certification for CNS licensure in California, while members and public commenters pressed for grandfathering or competency options for existing practitioners.

The Clinical Nurse Specialist Advisory Committee, an advisory body to the California Board of Registered Nursing, voted April 7 to direct staff to draft regulatory language that would add a national certification requirement to proposed rules for Clinical Nurse Specialist (CNS) licensure.

The motion — approved by roll call with four votes in favor and one absence — instructs board staff to prepare regulatory verbiage describing how a national certification requirement would operate and to return the draft to the committee in the fall for further review and public comment. Committee members said the directive is advisory: any change would require a full regulatory process and would not alter current licensure requirements until regulations or statute are finalized.

Why it matters: Board staff and members said national certification would align CNS licensure with the APRN consensus model used for other advanced practice nurses, improve interstate portability, and support eventual billing or independent practice pathways that rely on national credentials. Opponents and several public commenters warned that many currently practicing CNSs in California lack specialty national exams and could be excluded without grandfathering or interim competency pathways, imperiling the existing workforce and preceptorship capacity.

Committee debate and public input Board staff framed the choice as a trade‑off: requiring national certification creates a clear, monitorable metric (like NP/CRNA national exams) that reduces the board’s need for intrusive academic program oversight; licensing on completion of state programs without a national exam would force the board to design and run more detailed academic oversight and program review.

Loretta, a board executive staff member, told the committee the choice also affects federal and interstate issues: “Your vote today does nothing to the status quo until law is changed,” she said, noting regulatory adoption often takes two to three years and that grandfathering or delayed implementation options could be written into any future rule. She also described limits on CMS billing and the APRN compact that make national certification valuable for portability and reimbursement.

Several committee members argued for national certification to secure long‑term gains for the profession. One member said requiring national exams would push testing organizations to reinstate or create CNS specialty exams, noting California’s size gives it leverage.

But public commenters and some committee members pushed back. Alina Swatlo, representing a California CNS organization, urged inclusion of transitional language and warned that “if you just say require national certification…that would risk an unnecessary contraction of [a] highly skilled advanced practice workforce,” noting many California CNSs currently practice without the specific national exams for their specialties.

The motion and vote A motion to include a national certification requirement in the proposed CNS regulatory language was moved and seconded during item 8.0. After a public comment period and further committee discussion, the advisory committee recorded a roll‑call vote: Jessica Lycap (yes), Alyssa Brown (yes), Carrie Krogan (yes), Elizabeth Scruff (yes); Marilyn Ababio absent. The committee’s direction is to draft the regulatory text and present it to the advisory body in the fall; any final regulatory change would require subsequent public notice and formal rulemaking.

Next steps and context Board staff said they will draft language that can include grandfathering or competency‑based equivalency provisions if the committee asks, and will return the proposed text for another round of committee and public review. Staff reiterated that a regulatory change is not immediate: it must pass through the board’s regulatory process and public comment periods before taking effect, a timeline staff estimated at two to three years in typical cases.

The discussion took place against a backdrop of workforce concerns: staff presented data showing declining counts of active CNS licenses and very few disciplinary actions in recent years. Committee members linked the decline to closures of CNS programs and the limited availability of national certification exams for some CNS specialties.

The advisory committee adjourned after confirming the drafting direction; the draft regulations will be returned to the committee for review in the fall and will undergo the Board’s standard public‑notice rulemaking process if the committee advances them.